Stoke Therapeutics (STOK) Institutional Ownership $9.18 -0.18 (-1.92%) Closing price 04:00 PM EasternExtended Trading$9.18 0.00 (0.00%) As of 07:01 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Stoke Therapeutics (NASDAQ:STOK)Number ofInstitutional Buyers(last 12 months)75TotalInstitutional Inflows(last 12 months)$233.43MNumber ofInstitutional Sellers(last 12 months)34TotalInstitutional Outflows(last 12 months)$93.50M Get STOK Insider Trade Alerts Want to know when executives and insiders are buying or selling Stoke Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data STOK Institutional Buying and Selling by Quarter Stoke Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/23/2025 Siren L.L.C.2,247,347$14.95M0.9%+12.4%4.116% 5/19/2025 Jane Street Group LLC26,978$179K0.0%+125.2%0.049% 5/16/2025 Goldman Sachs Group Inc.1,662,039$11.05M0.0%+21.4%3.044% 5/16/2025 MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.24,167$162K0.0%+5.0%0.044% 5/16/2025 Jacobs Levy Equity Management Inc.357,248$2.38M0.0%N/A0.654% 5/16/2025 Granahan Investment Management LLC660,430$4.39M0.2%+16.3%1.210% 5/16/2025 Checkpoint Capital L.P.730,717$4.86M2.7%+139.3%1.338% 5/16/2025 AQR Capital Management LLC12,847$85K0.0%-45.6%0.024% 5/16/2025 ADAR1 Capital Management LLC30,085$200K0.0%N/A0.055% 5/15/2025 Redmile Group LLC4,485,981$29.83M2.8%-2.3%8.217% Get the Latest News and Ratings for STOK and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Stoke Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 5/15/2025 MPM Bioimpact LLC693,988$4.62M0.8%+1.2%1.271% 5/15/2025 DAFNA Capital Management LLC443,998$2.95M0.8%+159.5%0.813% 5/15/2025 Siren L.L.C.2,247,347$14.95M0.9%+12.4%4.116% 5/15/2025 Trexquant Investment LP86,140$573K0.0%-16.4%0.158% 5/14/2025 Rafferty Asset Management LLC61,706$410K0.0%-8.2%0.113% 5/14/2025 AlphaQuest LLC10,832$72K0.0%N/A0.020% 5/14/2025 Erste Asset Management GmbH396,000$2.67M0.0%N/A0.725% 5/14/2025 Wellington Management Group LLP135,960$904K0.0%+0.9%0.249% 5/13/2025 Fox Run Management L.L.C.13,780$92K0.0%N/A0.025% 5/13/2025 Russell Investments Group Ltd.16,119$107K0.0%N/A0.030% 5/12/2025 Nuveen LLC108,087$719K0.0%N/A0.198% 5/12/2025 Invesco Ltd.26,183$174K0.0%+117.0%0.048% 5/9/2025 Deutsche Bank AG25,566$170K0.0%-92.7%0.047% 5/9/2025 Charles Schwab Investment Management Inc.310,307$2.06M0.0%-9.3%0.568% 5/9/2025 Vanguard Group Inc.2,784,202$18.52M0.0%+1.9%5.100% 5/8/2025 US Bancorp DE11,222$75K0.0%+9,743.9%0.021% 5/8/2025 XTX Topco Ltd40,181$267K0.0%N/A0.074% 5/7/2025 Dauntless Investment Group LLC28,600$190K0.2%N/A0.052% 5/6/2025 Kennondale Capital Management LLC42,100$280K0.3%N/A0.077% 4/30/2025 Alps Advisors Inc.39,890$265K0.0%-6.9%0.073% 4/29/2025 Bank of New York Mellon Corp89,985$598K0.0%-3.4%0.165% 4/15/2025 Net Worth Advisory Group20,741$138K0.0%N/A0.038% 4/15/2025 Assenagon Asset Management S.A.959,603$6.38M0.0%-29.0%1.774% 4/7/2025 GAMMA Investing LLC5,360$36K0.0%+1,842.0%0.010% 3/24/2025 Wellington Management Group LLP134,812$1.49M0.0%-1.6%0.249% 3/18/2025 California State Teachers Retirement System32,068$354K0.0%+16.2%0.061% 2/19/2025 Toronto Dominion Bank3,173,258$35.00M0.1%N/A5.991% 2/17/2025 UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC95,505$1.05M0.0%+123.7%0.180% 2/17/2025 Voloridge Investment Management LLC86,888$958K0.0%-29.4%0.164% 2/17/2025 Squarepoint Ops LLC120,242$1.33M0.0%+6.7%0.227% Alpha Zone Pro beats 6 traditional indicators? (Ad)I’m not trying to toot my own horn or anything like that… But Matt and I might have just created the most innovative day trading system for the SPY out there. I mean consider this… How many technical indicators can tell when the SPY will likely breakout or breakdown – before it happens? The RSI… Bollinger bands… Trend lines… Fibonacci… Heck! Even the Elliot wave or MACD. How many can tell – with near 100% precision – the SPYs exact move for the day? But just this week alone, Alpha Zone Pro has successfully pointed us to the exact direction the SPY was going to move.That’s one of the things Alpha Zone Pro was designed to do See for yourself.2/17/2025 Two Sigma Investments LP53,950$595K0.0%-53.8%0.102% 2/17/2025 Tang Capital Management LLC300,000$3.31M0.2%N/A0.566% 2/17/2025 Toronto Dominion Bank3,173,258$35.00M0.1%N/A5.991% 2/17/2025 RTW Investments LP5,123,525$56.51M0.9%+10.1%9.673% 2/17/2025 Rafferty Asset Management LLC67,227$742K0.0%-18.8%0.127% 2/17/2025 Redmile Group LLC4,593,629$50.67M3.5%-2.5%8.672% 2/17/2025 ProShare Advisors LLC12,626$139K0.0%N/A0.024% 2/17/2025 MPM Bioimpact LLC685,826$7.57M1.1%+43.0%1.295% 2/17/2025 Millennium Management LLC76,829$847K0.0%+417.9%0.145% 2/17/2025 Group One Trading LLC104,411$1.15M0.0%+2.8%0.197% 2/17/2025 Graham Capital Management L.P.18,634$206K0.0%+8.5%0.035% 2/17/2025 Granahan Investment Management LLC567,689$6.26M0.3%-12.0%1.072% 2/17/2025 D. E. Shaw & Co. Inc.28,043$309K0.0%-83.6%0.053% 2/17/2025 Deutsche Bank AG350,614$3.87M0.0%-24.2%0.662% 2/17/2025 DAFNA Capital Management LLC171,097$1.89M0.5%-17.5%0.323% 2/17/2025 Baker BROS. Advisors LP4,633,838$51.11M0.5%+6.1%8.748% 2/17/2025 Bank of America Corp DE9,091$100K0.0%-92.7%0.017% 2/17/2025 BNP Paribas Financial Markets4,422$49K0.0%-94.2%0.008% 2/17/2025 Ameriprise Financial Inc.10,527$116K0.0%-26.5%0.020% 2/14/2025 Jane Street Group LLC11,977$132K0.0%-96.4%0.023% 2/14/2025 Freestone Grove Partners LP18,049$199K0.0%N/A0.034% 2/14/2025 Schonfeld Strategic Advisors LLC291,795$3.22M0.0%N/A0.551% 2/14/2025 Northern Trust Corp350,788$3.87M0.0%+3.4%0.662% 2/14/2025 Tudor Investment Corp ET AL18,258$201K0.0%N/A0.034% 2/14/2025 Gilder Gagnon Howe & Co. LLC92,546$1.02M0.0%+2.0%0.175% 2/14/2025 Price T Rowe Associates Inc. MD37,455$414K0.0%+6.3%0.071% 2/14/2025 Tower Research Capital LLC TRC11,930$132K0.0%+70.1%0.023% 2/14/2025 Dimensional Fund Advisors LP538,900$5.94M0.0%+103.4%1.017% 2/13/2025 CANADA LIFE ASSURANCE Co9,716$107K0.0%-14.4%0.018% 2/13/2025 Marshall Wace LLP951,432$10.49M0.0%-43.1%1.796% 2/13/2025 Renaissance Technologies LLC129,043$1.42M0.0%N/A0.244% 2/13/2025 Legal & General Group Plc35,347$390K0.0%-5.7%0.067% 2/13/2025 Invesco Ltd.12,065$133K0.0%N/A0.023% 2/13/2025 Wells Fargo & Company MN16,786$185K0.0%+51.2%0.032% 2/12/2025 Trexquant Investment LP103,031$1.14M0.0%-36.3%0.195% 2/12/2025 Geode Capital Management LLC877,095$9.68M0.0%+0.7%1.656% 2/12/2025 Wellington Management Group LLP134,812$1.49M0.0%-1.6%0.255% 2/12/2025 Norges Bank314,800$3.47M0.0%N/A0.594% 2/12/2025 JPMorgan Chase & Co.19,964$220K0.0%+29.2%0.038% 2/11/2025 EntryPoint Capital LLC31,968$353K0.1%N/A0.060% 2/11/2025 Corebridge Financial Inc.17,861$197K0.0%-6.1%0.034% 2/11/2025 Vanguard Group Inc.2,731,198$30.13M0.0%-1.0%5.156% 2/11/2025 KLP Kapitalforvaltning AS5,700$63K0.0%N/A0.011% 2/11/2025 Teacher Retirement System of Texas10,219$113K0.0%N/A0.019% 2/10/2025 Swiss National Bank67,300$742K0.0%+20.4%0.127% 2/6/2025 Charles Schwab Investment Management Inc.342,129$3.77M0.0%+8.2%0.646% 2/5/2025 Skorpios Trust6,906,181$76.18M99.8%-22.5%13.038% 2/4/2025 Los Angeles Capital Management LLC43,438$479K0.0%-57.8%0.082% 2/4/2025 Bank of New York Mellon Corp93,195$1.03M0.0%+1.4%0.176% 1/30/2025 Rhumbline Advisers49,374$545K0.0%+6.0%0.093% Only a handful of people know the setup that's defied these chaotic markets. (Ad)Since February, we've hit 28 out of 29 trades – that's a 96% win rate taking simple options setups on one single ticker every day. That's why Jack Carter and I teamed up to reveal The 4PM Payout Plan. Our goal here was to show you how to take these daily setups every morning to collect a 4PM payout. Naturally, no one can guarantee what the market does in the future… But these simple daily options setups have paid out with the market rallying, dropping, or staying flat. And if you want to be one of the few to not just know the ropes behind these daily setups but also deploy them for yourself…Go here now to get started on what could become your first 4PM payout.1/24/2025 China Universal Asset Management Co. Ltd.11,231$124K0.0%N/A0.021% 1/17/2025 SG Americas Securities LLC10,768$119K0.0%-27.8%0.020% 1/14/2025 Assenagon Asset Management S.A.1,350,925$14.90M0.0%+2.9%2.551% 12/13/2024 Exome Asset Management LLC176,600$2.17M1.5%N/A0.333% 11/27/2024 Franklin Resources Inc.22,314$285K0.0%-98.2%0.042% 11/19/2024 Barclays PLC79,740$980K0.0%+145.3%0.151% 11/16/2024 Geode Capital Management LLC870,831$10.71M0.0%+9.7%1.644% 11/15/2024 Barclays PLC79,740$980K0.0%+145.3%0.151% 11/15/2024 Jane Street Group LLC330,442$4.06M0.0%+338.2%0.624% 11/15/2024 Wellington Management Group LLP136,975$1.68M0.0%-4.6%0.259% (Data available from 1/1/2016 forward) STOK Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of STOK shares? During the previous two years, 114 institutional investors and hedge funds held shares of Stoke Therapeutics. The most heavily invested institutionals were Skorpios Trust ($76.18M), Lynx1 Capital Management LP ($70.05M), RTW Investments LP ($56.51M), Baker BROS. Advisors LP ($51.11M), Cowen AND Company LLC ($39.56M), Toronto Dominion Bank ($35.00M), and Redmile Group LLC ($29.83M).Learn more on STOK's institutional investors. Which institutional investors have been buying Stoke Therapeutics stock? Of the 92 institutional investors that purchased Stoke Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Toronto Dominion Bank ($6.35M), Lynx1 Capital Management LP ($3.94M), Redmile Group LLC ($2.45M), Baker BROS. Advisors LP ($1.60M), Assenagon Asset Management S.A. ($1.51M), Healthcare of Ontario Pension Plan Trust Fund ($1.15M), and Logos Global Management LP ($1.05M). How much institutional buying is happening at Stoke Therapeutics? Institutional investors have bought a total of 27,708,051 shares in the last 24 months. This purchase volume represents approximately $307.73M in transactions. Which Stoke Therapeutics major shareholders have been selling company stock? Of the 47 institutional investors that sold Stoke Therapeutics stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Skorpios Trust ($3.94M), Franklin Resources Inc. ($1.19M), Marshall Wace LLP ($719.30K), Assenagon Asset Management S.A. ($547.05K), Deutsche Bank AG ($436.91K), Jane Street Group LLC ($318.47K), and Redmile Group LLC ($317.57K). How much institutional selling is happening at Stoke Therapeutics? Institutional investors have sold a total of 9,406,007 shares in the last 24 months. This volume of shares sold represents approximately $101.51M in transactions. Related Companies VCEL Major Shareholders NAMS Major Shareholders AAPG Major Shareholders BLTE Major Shareholders HRMY Major Shareholders DNLI Major Shareholders KYMR Major Shareholders KNSA Major Shareholders CGON Major Shareholders TARS Major Shareholders This page (NASDAQ:STOK) was last updated on 5/27/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Stoke Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Stoke Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
